Validation de la technique de biopsie du ganglion sentinelle dans le cancer du sein

[en] PURPOSE: Assessment of our experience and validation of the sentinel lymph node biopsy technique in breast cancer stage T0-T2N0M0 surgery. METHODS: Identification and biopsy of the sentinel lymph node by the radio colloid method in a consecutive series of 205 patients undergoing surgery for breast cancer stage T0-T2N0M0 between October 1998 and January 2007, initially in association with a complete axillary lymph node dissection (learning curve), later in an elective way. Prospective recording of the data and analysis with an average follow-up of 50 months (3 to 102 months). RESULTS: Biopsy rate of the sentinel lymph node of 90%, false negative rate of the method 2.5%, axillary recurrence rate 0%. CONCLUSION: We confirm in this series that the sentinel lymph node biopsy technique is a reliable approach in our experience for the evaluation of the axillary lymph node status in breast cancer stage T0-T2N0M0.

Disciplines :

Endocrinology, metabolism & nutrition
Radiology, nuclear medicine & imaging

Author, co-author :

Bleret, Valerie ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie

Lifrange, Eric ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie

Ghuysen, Vincent ; Centre Hospitalier Universitaire de Liège - CHU > Médecine nucléaire

Milet, J.

Fridman, Viviana ; Centre Hospitalier Universitaire de Liège - CHU > Anatomie pathologique

Colin, Claude ; Université de Liège - ULiège > Gynécologie - Obstétrique

Language :

French

Title :

Validation de la technique de biopsie du ganglion sentinelle dans le cancer du sein

Alternative titles :

[en] Validation of the Sentinel Lymph Node Biopsy in Breast Cancer

Publication date :

January 2008

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

37-42

Peer reviewed :

Peer reviewed

Available on ORBi :

since 07 May 2013

Statistics

Number of views

77 (4 by ULiège)

Number of downloads

2 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Goldhirsch A, Glick JH, Gelber RD, et al. - Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol. 2005, 16, 1569-1583.
Zurrida S, Morabito A, Galimberti V, et al. - Importance of the level of axillary involvement in relation to traditional variables in the prognosis of breast cancer. Int J Oncol, 1999, 15, 475-480.
Cody HS 3rd. - Sentinel lymph node biopsy for breast cancer: does anybody not need one? Ann Surg Oncol, 2003, 10, 1131-1132.
Krag DN, Harlow S. - Current statuts of sentinel node surgery in breast cancer. Oncology, 2003, 17, 1663-1666.
Giuliano AE, Kirgan DM, Guenther JM, Morton DL. - Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg, 1994, 220, 391-398.
Veronesi U, Paganelli G, Viale G, et al. - A randomised comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003; 349(6):546-553.
Veronesi U, Paganelli G, Viale G, et al. - Sentinel lymph node biopsy as a staging procedure in breast cancer : update of a randomised controlled study. Lancet Oncol, 2006, 7, 983-990.
Schwartz GF, Giuliano AE, Veronesi U. - Consensus Conference Committee. Proceeding of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22 2001, Philadelphia, Pennsylvania. Hum Pathol, 2002, 33, 579-589.
Bourgeois P, Nogaret JM, Veys I, et al. - Sentinel node biopsy. Eur J Nucl Med, 1998, 25, 1588-1590.
Cabanas RM. - An approach for the treatment of penile carcinoma. Cancer, 1977, 39, 456-466.
Krag Dn, Weaver DL, Alex JC, Fairbank JT. - Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol, 1993, 2, 335-339.
Nieweg OE, Estourgie SH, Valdes Olmos RA, et al. - Lymphatic mapping with tracer administration into the primary breast cancer. Eur J Surg Oncol, 2003, 39, 95-97.
Cody HS 3rd.- The learning curve for sentinel lymph node biopsy in breast cancer. Arch Surg, 2000, 135, 605-606.
Salmon RJ, Marcollet A, Doridot V, Clough KB. - Identification du ganglion sentinelle dans le cancer du sein: aspects logistiques. Bull Cancer, 2003, 90, 1049-1054.
Cody HS 3rd. - The sentinel node concept : a critique of the critique. Breast, 2006, 15, 571-574.
Cody HS 3rd. - Sentinel lymph node biopsy for breast cancer: indications, contraindications and new directions. J Surg Oncol, 2007, 95, 440-442.
Schrenk P, Rieger R, Shamiyeh A, Wayand W. - Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer, 2000, 88, 608-614.
Van Rijk MC, Tanis PJ, Nieweg OE, et al. - Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer. J Surg Oncol, 2006, 94, 281-286.
Linehan DC, Hill AD, Akhurst T, et al. - Intradermal radiocolloid and intraparenchymal blue dye injection optimise sentinel node identification in breast cancer patients. Ann Surg Oncol, 1999, 6, 450-454.
Defechereux T, Maweja S, Meurisse M. - Actualités thérapeutiques en chirurgie du cancer du sein : la technique du ganglion sentinelle. Rev Med Liège, 2007, 62, 410-413.
Van Rijk MC, Peterse JL, Nieweg OE, et al. - Additional axillary metastases and stage migration in breast cancer patients with micro metastases or submicro metastases in sentinel lymph nodes. Cancer, 2006, 107, 467-471.
Herman PH, Lifrange E, Nisolle M, et al. - Actualités thérapeutiques en gynécologie : pathologies organiques. Rev Med Liège, 2007, 62, 414-422.